Key Differences between Biosimilars and Generics

Okay, straight up: generics save a ton of money. In the U.S. they cut healthcare bills by $300B a year. Biosimilars arenu2019t small potatoes either u2014 the global market is projected to hit about $133B by 2030. But hereu2019s the annoying part: people mix them up. Generics and biosimilars both make drugs cheaper, but they behave very differently after a patent dies. Confusing the two will cost youu2014whether you run procurement, hunt licensing deals, or manage an investor portfolio.<br>More Info: https://clival.com/blog/key-differences-between-biosimilars-and-generics<br>

ClivalDatabase + Follow